Related Experiment Video
Updated: Jun 18, 2025

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
From pre-test and post-test probabilities to medical decision making
Michelle Pistner Nixon1, Farhani Momotaz1, Claire Smith2
1College of Information Science and Technology, Pennsylvania State University, University Park, PA, USA.
This study introduces a simple quantitative framework for clinical decisions, extending the Bayesian Pre-test/Post-test Probability (BPP) model. It integrates costs to aid clinicians in balancing diagnostic uncertainty with decision-making, simplifying complex choices.
Area of Science:
- Medical Decision-Making
- Bayesian Statistics
- Health Informatics
Background:
- Modern evidence-based medicine aims for simple tools to integrate quantitative data into clinical decisions.
- The Bayesian Pre-test/Post-test Probability (BPP) framework quantifies diagnostic uncertainty but doesn't fully address decision-making.
- Simple, flexible quantitative approaches for clinical decision-making remain elusive.
Purpose of the Study:
- To extend the BPP framework using Bayesian Decision Theory to incorporate costs for clinical decision-making.
- To develop a simple quantitative framework for binary clinical decisions.
Main Methods:
- Extension of the BPP framework by integrating concepts from Bayesian Decision Theory.
- Development of a quantitative framework for binary decisions (e.g., treat/no-treat).
Main Results:
- A simple quantitative framework for binary clinical decisions was developed.
- A critical value, the decision boundary (), was identified, representing the optimal point for action or inaction based on relative costs.
- The framework's utility was demonstrated through bedside case studies and a reanalysis of a study on probability misestimation.
Conclusions:
- The developed approach is a simple, core component of the BPP framework.
- It requires minimal resources (hand-held calculator) and is broadly applicable.
- It is particularly useful for patient-specific decisions with difficult-to-quantify costs and benefits.
More Related Videos
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Related Concept Videos
Decision Making: P-value Method
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can...
Decision Making: Traditional Method
First, a specific claim about the population parameter is decided based on the research question and is stated in a simple form. Further, an opposing statement to this claim is also stated. These statements can act as null and alternative hypotheses, out of which a null hypothesis would be a...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Testing a Claim about Population Proportion
There are two methods of testing a claim about a population proportion: (1) Using the sample proportion from the data where a binomial distribution is approximated to the normal distribution and (2) Using the binomial probabilities calculated from the data.
The first method uses normal distribution as an approximation to the binomial distribution. The requirements are as follows: sample size is large...
Errors In Hypothesis Tests
McNemar's Test